Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
Stock detail
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
TXG
10x Genomics, Inc.
NASDAQGS
Medical Devices
United States
$62.65
▼
-0.57 (-0.90%)
POST
—
OPEN
$62.73
HIGH
$63.48
LOW
$60.99
PREV CLOSE
$63.22
VOLUME
1.47M
0.46x avg
BID / ASK
44.47 / 65.00
spr 20.53
MARKET CAP
$8.16B
DAY RANGE
$60.99
$63.48
P/E (TTM)
—
Fwd 308.1
EPS (TTM)
-0.59
DIV YIELD
—
52W HIGH
$66.94
-6.4%
52W LOW
$11.16
+461.4%
BETA
2.04
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$62.52
-0.13
(-0.21%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
TXG
$62.65
▼
-0.90%
Chart
Valuation
Financials
Peers
News
TXG · K 線技術分析（即時、可互動）
basic
pro
快速分析（約 90–120 秒）
Loading K-line chart…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，約 90–120 秒。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
One-Year Trajectory
RISK-ON
252 BARS · +348.8% YOY
1-year price chart. Started at 13.96, currently 62.65, up 348.8 percent. Range 11.34 to 65.12 over 252 data points.
2025-09-05
$13.96 → $62.65 (+348.8%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE.
Data sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). All values cached for 5 minutes via ISR.
VALUATION
Deterministic Valuation (SEC EDGAR + Finnhub)
RISK-OFF
DCF FV $24.65 · -60.7% VS SPOT
DCF Fair Value
$24.65
DCF vs Spot
-60.7%
Comps Fair Value
—
WACC Used
+7.5%
Terminal g
+3.0%
Verdict: strong-sell
· DCF $24.65 (-60.7%)
⚠ Comparables skipped: no peer multiples or no per-share economics from Finnhub metric endpoint.
FINANCIALS
Multi-Year Financials (SEC XBRL)
CALM
YOY REV +5.2% · 3 FY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$642.8M
-$43.5M
$136.1M
$130.1M
$1.04B
2024-12
$610.8M
-$182.6M
$6.7M
-$5.7M
$918.6M
2023-12
$618.7M
-$255.1M
-$15.2M
-$63.8M
$965.1M
NEWS
Recent News (past 14 days)
CALM
10 HEADLINES · LAST 14 DAYS
3 Inflated Stocks with Open Questions
StockStory · 2026-09-04
10x Genomics Rallies 84% in 3 Months: Is There More Upside Ahead?
Zacks · 2026-09-03
10x Genomics Needs "Meaningful' Growth in Single-Cell Business, RBC Says
MT Newswires · 2026-09-01
RBC Initiates 10x Genomics at Sector Perform With $70 Price Target
MT Newswires · 2026-09-01
TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences
Zacks · 2026-08-31
Sector Update: Healthcare Stocks Decline Late Afternoon
MT Newswires · 2026-08-28
Sector Update: Healthcare
MT Newswires · 2026-08-28
10x Genomics Announces $4.8 Million Award in Patent Case Against Qiagen Unit
MT Newswires · 2026-08-28